Article

Dr. Haller honored

Ophthalmology Times Editorial Advisory Board member Julia A. Haller, MD, was formally named the first holder of the William Tasman, MD, Endowed Chair in Ophthalmology at the Wills Eye Institute on Sept. 8.

Philadelphia-Ophthalmology Times Editorial Advisory Board member Julia A. Haller, MD, was formally named the first holder of the William Tasman, MD, Endowed Chair in Ophthalmology at the Wills Eye Institute on Sept. 8.

The honor is named for the renowned retina surgeon who was ophthalmologist-in-chief at Wills for 22 years. Dr. Haller has held that title at the Institute since November 2007. She also is professor and chairwoman of the department of ophthalmology at Thomas Jefferson University and one of two directors of the Wills Vision Research Center at Jefferson.

Dr. Haller has published more than 250 papers in the peer-reviewed literature as well as 20 book chapters. She was president of the American Society of Retina Specialists from 2006 to 2008.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.